Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
CAN CSA C22.2 No. 60601-2-17-15 is the Canadian adoption of IEC 60601-2-17, part of the IEC 60601 series of medical electrical equipment safety standards. Published under the CSA Group’s C22.2 series, this standard specifies particular requirements for the basic safety and essential performance of automatically-controlled brachytherapy afterloading equipment. It is intended to be used in conjunction with CAN/CSA-C22.2 No. 60601-1, the general standard for medical electrical equipment. Compliance with this standard is mandatory for manufacturers seeking to market such equipment in Canada, as it is considered a safety standard under various provincial and territorial electrical codes.
CAN CSA C22.2 No. 60601-2-17-15 applies to automatically-controlled brachytherapy afterloading systems used for the treatment of cancer. These systems include the control console, source applicators, transfer tubes, and all associated software and electrical subsystems. The standard covers equipment that uses sealed radioactive sources (e.g., iridium-192, cobalt-60) which are remotely loaded into applicators placed in or near the target tissue.
Key aspects of the scope include:
The standard excludes manually-loaded afterloading systems and equipment intended solely for external beam radiotherapy. It also clarifies that it does not prescribe clinical performance criteria related to treatment outcome.
The standard imposes stringent control over dose accuracy to ensure patient safety. The system must verify source position and dwell times against the treatment plan before and during delivery. Limits are placed on the deviation of delivered dose from the prescribed dose, typically within ±5% for high-dose-rate (HDR) systems. Source activity checks and timing accuracy requirements are also specified.
In accordance with the general standard CAN/CSA-C22.2 No. 60601-1, the particular standard adds requirements for mechanical strength, prevention of unintended source movement, protection against electromagnetic disturbances, and safe handling of sources. Connector systems must be designed to prevent incorrect coupling, and all transfer pathways must be tested for kink or obstruction risks.
Programmable electrical medical systems (PEMS) used for afterloading control must undergo rigorous validation. The standard requires a documented software life cycle that includes hazard analysis, unit and integration testing, and verification of safety functions. Real-time operating systems must guarantee deterministic response to interlock conditions, and any network connectivity must be assessed for cybersecurity threats.
CAN CSA C22.2 No. 60601-2-17-15 mandates multiple independent alarms to indicate problems such as source stuck, incorrect source position, loss of electrical power, or interruption of cooling. A visual and audible alarm must activate at a radiation monitor exceeding a set threshold. The system must also include a manual emergency retraction mechanism that is physically separate from computer controls and capable of withdrawing the source into its shielded container under all power conditions.
The following table summarizes some of the key technical requirements and typical performance criteria specified in the standard (based on the IEC edition).
| Requirement Category | Parameter / Test | Typical Requirement |
|---|---|---|
| Source Positioning | Accuracy of source travel distance | Within ±1 mm of planned coordinates |
| Dose Delivery | Overall treatment time deviation | ≤ 5% of planned time |
| Emergency Systems | Source retraction time after activation | ≤ 15 seconds |
| Interlocks | Response time to detect door open or probe disconnect | ≤ 100 ms |
| Radiation Leakage | Surface dose rate at 5 cm from shielded container | ≤ 0.5 mR/h |
| Software Safety | Audit trail integrity | Non-rewritable log with time‑stamped events |
Manufacturers must demonstrate conformity to CAN CSA C22.2 No. 60601-2-17-15 before placing brachytherapy afterloading equipment on the Canadian market. Compliance routes typically involve testing by a recognized certification body (e.g., CSA, Intertek, UL). The standard is a “hybrid” document: it must be used together with the general standard CAN/CSA-C22.2 No. 60601-1 and any collateral standards (e.g., 60601-1-2 for EMC, 60601-1-6 for usability).
Key implementation steps include: